Daniela Nürnberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daniela Nürnberg has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Aline Isabel Riechardt
Klinik und Poliklinik für Augenheilkunde, Charité – Universitätsmedizin Berlin, Berlin
1 shared publicationAntonia M. Joussen
Klinik und Poliklinik für Augenheilkunde, Charité – Universitätsmedizin Berlin, Berlin
1 shared publication- Chun-Xia Yi
Department of Endocrinology and Metabolism, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlands
1 shared publication Claudia Brockmann
Klinik und Poliklinik für Augenheilkunde, Charité – Universitätsmedizin Berlin, Berlin
1 shared publication- Georg Homuth
Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany
1 shared publication - Gunnar Kleinau
Institute of Medical Physics and Biophysics, Charité - Universitätsmedizin
1 shared publication
Latest Publications
- 14 September 2018
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 235 (09) , 1001-1012
Multimodale Bildgebung des Aderhautmelanoms mit seinen Differenzialdiagnosen, Therapie (Bestrahlungsplanung) und Verlaufskontrolle
Zusammenfassung: Die Bildgebung von intraokularen Tumoren ist multimodal, vielseitig einsetzbar, in stetiger Weiterentwicklung. Sie ist damit unerlässlich für die Erkennung, Diagnose, Therapieplanung und Überwachung von intraokularen Tumoren. Für die Diagnostik und Verlaufskontrolle steht ein breites Spektrum bildgebender Verfahren zur Verfügung: die Farbbildaufnahme, Infrarotaufnahme, Autofluoreszenzaufnahme, Fluoreszenzangiografie (FAG) und Indocyaningrünangiografie (ICGA), optische Kohärenztomografie (OCT) und die Sonografie (US). In dieser Arbeit wird an verschiedenen Beispielen die multimodale Nutzung von Bildgebungsverfahren in der Diagnose, Therapie und Nachsorge okulärer Tumoren unter besonderer Berücksichtigung der Aderhautmelanome beschrieben.
- 14 September 2018
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 235 (09) , 1001-1012
Multimodale Bildgebung des Aderhautmelanoms mit seinen Differenzialdiagnosen, Therapie (Bestrahlungsplanung) und Verlaufskontrolle
Zusammenfassung: Die Bildgebung von intraokularen Tumoren ist multimodal, vielseitig einsetzbar, in stetiger Weiterentwicklung. Sie ist damit unerlässlich für die Erkennung, Diagnose, Therapieplanung und Überwachung von intraokularen Tumoren. Für die Diagnostik und Verlaufskontrolle steht ein breites Spektrum bildgebender Verfahren zur Verfügung: die Farbbildaufnahme, Infrarotaufnahme, Autofluoreszenzaufnahme, Fluoreszenzangiografie (FAG) und Indocyaningrünangiografie (ICGA), optische Kohärenztomografie (OCT) und die Sonografie (US). In dieser Arbeit wird an verschiedenen Beispielen die multimodale Nutzung von Bildgebungsverfahren in der Diagnose, Therapie und Nachsorge okulärer Tumoren unter besonderer Berücksichtigung der Aderhautmelanome beschrieben.
- Open Access
- 10 November 2014
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (11) , 20638-20655
Analysis of Human TAAR8 and Murine Taar8b Mediated Signaling Pathways and Expression Profile
The thyroid hormone derivative 3-iodothyronamine (3-T1AM) exerts metabolic effects in vivo that contradict known effects of thyroid hormones. 3-T1AM acts as a trace amine-associated receptor 1 (TAAR1) agonist and activates Gs signaling in vitro. Interestingly, 3-T1AM-meditated in vivo effects persist in Taar1 knockout-mice indicating that further targets of 3-T1AM might exist. Here, we investigated another member of the TAAR family, the only scarcely studied mouse and human trace-amine-associated receptor 8 (Taar8b, TAAR8). By RT-qPCR and locked-nucleic-acid (LNA) in situ hybridization, Taar8b expression in different mouse tissues was analyzed. Functionally, we characterized TAAR8 and Taar8b with regard to cell surface expression and signaling via different G-protein-mediated pathways. Cell surface expression was verified by ELISA, and cAMP accumulation was quantified by AlphaScreen for detection of Gs and/or Gi/o signaling. Activation of G-proteins Gq/11 and G12/13 was analyzed by reporter gene assays. Expression analyses revealed at most marginal Taar8b expression and no gender differences for almost all analyzed tissues. In heart, LNA-in situ hybridization demonstrated the absence of Taar8b expression. We could not identify 3-T1AM as a ligand for TAAR8 and Taar8b, but both receptors were characterized by a basal Gi/o signaling activity, a so far unknown signaling pathway for TAARs.
- 10 November 2014
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (11) , 20638-20655
Open AccessAnalysis of Human TAAR8 and Murine Taar8b Mediated Signaling Pathways and Expression Profile
The thyroid hormone derivative 3-iodothyronamine (3-T1AM) exerts metabolic effects in vivo that contradict known effects of thyroid hormones. 3-T1AM acts as a trace amine-associated receptor 1 (TAAR1) agonist and activates Gs signaling in vitro. Interestingly, 3-T1AM-meditated in vivo effects persist in Taar1 knockout-mice indicating that further targets of 3-T1AM might exist. Here, we investigated another member of the TAAR family, the only scarcely studied mouse and human trace-amine-associated receptor 8 (Taar8b, TAAR8). By RT-qPCR and locked-nucleic-acid (LNA) in situ hybridization, Taar8b expression in different mouse tissues was analyzed. Functionally, we characterized TAAR8 and Taar8b with regard to cell surface expression and signaling via different G-protein-mediated pathways. Cell surface expression was verified by ELISA, and cAMP accumulation was quantified by AlphaScreen for detection of Gs and/or Gi/o signaling. Activation of G-proteins Gq/11 and G12/13 was analyzed by reporter gene assays. Expression analyses revealed at most marginal Taar8b expression and no gender differences for almost all analyzed tissues. In heart, LNA-in situ hybridization demonstrated the absence of Taar8b expression. We could not identify 3-T1AM as a ligand for TAAR8 and Taar8b, but both receptors were characterized by a basal Gi/o signaling activity, a so far unknown signaling pathway for TAARs.